Case Report: Ofatumumab for the treatment of refractory anti-NMDAR-positive autoimmune encephalitis - Top-Institutions - MDSpire

Case Report: Ofatumumab for the treatment of refractory anti-NMDAR-positive autoimmune encephalitis

  • By

  • Yekai Ma

  • Yani Tang

  • Qinyue Peng

  • Weiqing Zhang

  • Yongjun Wu

  • Jun Chen

  • Susu Xiong

  • Dong Lv

  • June 10, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Neurology
    • Autoimmune Neurology

  • #2

    Hospitals of the University of Pennsylvania–Penn Presbyterian
    Hospitals of the University of Pennsylvania–Penn Presbyterian

    Philadelphia, Pennsylvania

    Key Differentiators

    • Neurology
    • Autoimmune Neurology

Original Source(s)

Case Report: Ofatumumab for the treatment of refractory anti-NMDAR-positive autoimmune encephalitis

  • by Yekai Ma, Yani Tang, Qinyue Peng, Weiqing Zhang, Yongjun Wu, Jun Chen, Susu Xiong, Dong Lv

  • June 10, 2026

Related Content

Acetylcholine receptor antibody-positive myasthenia gravis and Kennedy’s disease overlap syndrome: a case report and literature review

Comparative analysis of diagnostic expectations between adults referred for ADHD and autism assessment: a thematic analysis

Gut dysbiosis and systemic inflammation in elderly hypertensive patients with amnestic mild cognitive impairment